epirubicin has been researched along with nedaplatin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fujikawa, N; Hattori, Y; Kakizoe, M; Kishida, T; Kondo, K; Kubota, Y; Nakaigawa, N; Noguchi, K; Saito, K; Takizawa, A; Teranishi, J | 1 |
| Ishiguro, K; Nishimura, M; Suda, T; Uchida, N | 1 |
2 other study(ies) available for epirubicin and nedaplatin
| Article | Year |
|---|---|
[Clinical study of combination chemotherapy of methotrexate, epirubicin and nedaplatin (MEN) in patients with advanced urothelial carcinoma].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Drug Administration Schedule; Epirubicin; Female; Humans; Kidney Neoplasms; Kidney Pelvis; Male; Methotrexate; Middle Aged; Organoplatinum Compounds; Quality of Life; Remission Induction; Survival Rate; Urinary Bladder Neoplasms | 2007 |
[A case of aggressive primary squamous cell carcinoma of the breast refractory to preoperative neoadjuvant chemotherapy].
Topics: Adult; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Squamous Cell; Cyclophosphamide; Epirubicin; Fatal Outcome; Female; Fluorouracil; Humans; Lung Neoplasms; Neoadjuvant Therapy; Organoplatinum Compounds; Paclitaxel; Vinblastine; Vinorelbine | 2009 |